This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Planning for the future? Find effective ways to save for future goals and ensure you reach your financial aspirations.
17,671 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
More than 100 million U.S. adults cannot pay their credit-card balances in full, a sign of growing financial strain a...
Fed chair Powell kept policy steady as he hailed resilience in the U.S. economy, while warning that inflation and ene...
Discover how nyxoah (nyxh) 2025 earnings could shape an investor's view of MedTech plays. This forward-looking analys...
Nebius Group launches a $4 billion convertible-note round to accelerate a 1.2 GW AI data center project, backed by Nv...
MSFO continues to pay weekly distributions despite a sharp stock slide in Microsoft. As MSFT falls, MSFO investors we...
ProShares Ultra Bloomberg Crude Oil 2x (UCO) has surged about 125% this year, yet traders warn a hidden structural ri...
Bitcoin vaulted past $70,000 in minutes, sending a broad risk-on rally across assets. Analysts warn the move produced...
Mark Cuban envisions AI enabling workers to finish earlier without a pay cut, a bold bet that could reshape budgets, ...
Apple faces a window of opportunity as upbeat quarterly results and expanding services/supporting growth drivers push...
Insider moves can ripple through biotech stocks. This piece breaks down recent tarsus pharma stock insider activity, ...
Lumentum’s March 23 S&P 500 inclusion has sparked renewed buying and a broader market debate about how far the rally ...